Close
Digital Health & Ai Innovation summit 2026
APE 2026

Hitachi Medical Systems Europe Introduces Third-Generation Intelligent Vector Flow Mapping

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Novartis Plans its Fourth US Radioligand...

Novartis, which is a world-leading innovative medicines company, has...

Tempus-NYU Langone Collaboration Advances Precision Oncology

Tempus and NYU Langone Health have signed a multi-year...

Boston Scientific Valencia Acquisition Expands Portfolio

Boston Scientific has entered into an agreement to acquire...

Hitachi Medical Systems Europe introduced what it calls the next level of intelligent Vector Flow Mapping (iVFM) at EuroEcho Imaging 2018, Dec. 5-8 in Milan, Italy.

The third generation of Hitachi’s non-invasive intracardiac blood flow visualization technology provides unique information about the intraventricular vortex and its energetic efficiency, including kinetic energy loss, relative pressure, or wall shear stress display and analysis.

Built on the premium 2-D/4-D/4G CMUT Lisendo 880LE ultrasound system as part of the HDAnalytics CV analysis package, the new iVFM features faster data processing through automation for a simplified workflow. The embedded iVFM is now available for both intracardiac and vascular flow structures.

Prof.Jose Luis Zamorano, professor of medicine, head of cardiology at the University Hospital Ramón y Cajal, Madrid, Spain, said, “VFM offers a better insight into cardiac physiology and is a new way of analyzing cardiac resynchronization therapy responders. VFM is easy to analyze and makes creates a better understanding of cardiac diseases”.

For more information: www.hitachi-medical-systems.eu

Latest stories

Related stories

Novartis Plans its Fourth US Radioligand Therapy Facility

Novartis, which is a world-leading innovative medicines company, has...

Tempus-NYU Langone Collaboration Advances Precision Oncology

Tempus and NYU Langone Health have signed a multi-year...

Boston Scientific Valencia Acquisition Expands Portfolio

Boston Scientific has entered into an agreement to acquire...

Haemonetics Vivasure Acquisition Reaches Valuation of €185M

Haemonetics has agreed to acquire Vivasure Medical for up...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »